Stay in the know
Receive timely insights and briefings from HSF Kramer, tailored to keep you informed and ahead
Subscribe now
Herbert Smith Freehills Kramer (HSF Kramer) is pleased to be advising CSL on its recently announced proposed demerger of its Seqirus business (Seqirus) as a standalone ASX-listed entity by the end of Financial Year 2026.
Seqirus is one of the world’s largest influenza vaccine providers, dedicated to advancing public health through innovative vaccine solutions and pandemic preparedness.
The HSF Kramer team is led by partners Priscilla Bryans, Baden Furphy, Alexander Mackinnon, and Michael Ziegelaar, with partner Ryan Leslie advising on the tax aspects of the transaction.
Key contacts
Priscilla Bryans
Partner, Melbourne
Baden Furphy
Partner, Melbourne
Alexander Mackinnon
Partner, Melbourne
Michael Ziegelaar
Partner, Melbourne
Ryan Leslie
Partner, Melbourne
Media contact
For further information on this news article, please contact:
Gina Baldassarre
External Communications Manager
Sydney
More news
31 7月 2026
HSF Kramer advises the Clean Energy Finance Corporation and Aviva Investors on their A$142m co-investment in Tasmanian sustainable forestry plantations
Herbert Smith Freehills Kramer has advised the Clean Energy Finance Corporation (CEFC) and Aviva Investors on their investment alongside Gresham House in …
29 7月 2026
Herbert Smith Freehills Kramer conseille Orange dans le cadre de son projet de création d'une coentreprise dédiée aux data centers avec Morrison
Herbert Smith Freehills Kramer a conseillé Orange dans le cadre de la signature d'un accord d'exclusivité avec Morrison, l'un des principaux …
24 7月 2026
Herbert Smith Freehills Kramer advises Aware Super on tax aspects of acquiring a further 25.1% interest in retirement village operator Keyton
Herbert Smith Freehills Kramer has provided tax advice to superannuation fund Aware Super in relation to its acquisition of a further 25.1% interest in …